Document is current
Any future updates will be listed below
-
Authors
Othman, Mohamed O.
Kort, Jens J.
Ramsey, Mitchell L.
Gonda, Tamas A.
Lara, Luis F.
Jazrawi, Saad
Keihanian, Tara
Park, Walter
Brett, Neil R.
Harb, Diala
Li, Moming
Trikudanathan, Guru
-
Funding
Funding for this research was provided by:
AbbVie
- License Information
-
More Information
Article History
Received: 22 January 2026
Accepted: 27 April 2026
First Online: 13 May 2026
Declarations
:
: MLR, SJ, and TAG have no relevant disclosures. DH, JJK, and ML are full-time employees of AbbVie Inc. and may hold AbbVie Inc. stock. TK serves as a consultant for ConMed, Lumendi, and Neptune Medical. LFL serves as a consultant and on a speakers bureau for AbbVie Inc. MOO serves as a consultant for AbbVie, Apollo, Boston Scientific Corporation, ConMed, Creo Medical, Lumendi, and Olympus and has received grant/research support from AbbVie, Boston Scientific Corporation, ConMed, and Lucid Diagnostics. WP is a consultant and advisory committee/board member for AbbVie, Ariel Medicine, Pfizer, Ionis, Horizon Therapeutics, and Nestle; a consultant for Acumen, Olympus, Arctx Medical, and Capsovision; and holds stock/stock options in Arctx Medical. NRB is an employee of PPD, part of Thermo Fisher Scientific, which was funded by AbbVie to conduct the analysis. GT serves as a consultant for Boston Scientific Corporation.
